Want to see IT:BMED full AI Analyst Report?
BMED Stock Chart & Stats
€22.74
€0.10(0.44%)
At close: 4:00 PM EDT
€22.74
€0.10(0.44%)
Day’s Range― - ―
52-Week Range€15.79 - €24.32
Previous CloseN/A
Volume801.32K
Average Volume (3M)1.19M
Market Cap
€17.09B
Enterprise Value€21.22K
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€1.85B
Price to Earnings (P/E)13.1
Beta1.16
Next Earnings
Nov 10, 2026EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend Yield5.39%
Share Statistics
EPS (TTM)1.72
Shares Outstanding745,413,900
10 Day Avg. Volume1,292,738
30 Day Avg. Volume1,192,469
Financial Highlights & Ratios
PEG Ratio1.10
Price to Book (P/B)3.20
Price to Sales (P/S)2.82
P/FCF Ratio2.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€24.33Price Target Upside7.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.51
Revenue Forecast (FY)€2.44B
Bulls Say, Bears Say
Bulls Say
High ROEVery strong ROE (~27–28%) indicates efficient use of capital and durable earnings generation. High returns support internal capital formation, dividend capacity and reinvestment into distribution and tech, providing structural financial strength over the coming months.
Improved Cash GenerationMaterially stronger operating and free cash flow in 2024–2025, with FCF tracking net income, reflects high earnings-to-cash quality. Reliable cash conversion enhances flexibility for dividends, banker hiring and AI/digital investments while lowering short-to-medium term refinancing risk.
Diversified Fee Model & Adviser NetworkFee income growth plus adviser network expansion underpin recurring, scalable revenue less reliant on rates. A multi-channel distribution with growing top-tier bankers supports asset-gathering, cross-sell and steady management fees, strengthening structural revenue resilience.
Bears Say
Leverage VolatilityHistoric swings in leverage demonstrate balance-sheet instability and higher financial risk in stressed periods. Such volatility can constrain capital planning, elevate funding costs under stress and complicate regulatory ratios despite the improved 2025 position.
NII Sensitivity To RatesManagement’s NII outlook depends on specific Euribor assumptions, making net interest income and margin trajectories vulnerable to rate shifts and repricing dynamics. If rates or spreads evolve unfavorably, structural NII growth and margin sustainability could weaken.
Earnings Timing & Non‑Recurring ItemsLarge deferred performance fees and notable non-recurring items create timing-related earnings volatility. Reliance on performance fees and variable certificate-driven fees makes underlying recurring profitability harder to assess and raises risk to sustainable dividend and earnings quality.
Banca Mediolanum SpA News
BMED FAQ
What was Banca Mediolanum SpA’s price range in the past 12 months?
Banca Mediolanum SpA lowest stock price was €15.79 and its highest was €24.32 in the past 12 months.
What is Banca Mediolanum SpA’s market cap?
Banca Mediolanum SpA’s market cap is €17.09B.
When is Banca Mediolanum SpA’s upcoming earnings report date?
Banca Mediolanum SpA’s upcoming earnings report date is Nov 10, 2026 which is in 95 days.
How were Banca Mediolanum SpA’s earnings last quarter?
Banca Mediolanum SpA released its earnings results on Jul 30, 2026. The company reported €0.384 earnings per share for the quarter, beating the consensus estimate of €0.359 by €0.025.
Is Banca Mediolanum SpA overvalued?
According to Wall Street analysts Banca Mediolanum SpA’s price is currently Undervalued.
Does Banca Mediolanum SpA pay dividends?
Banca Mediolanum SpA pays a Semiannually dividend of €0.65 which represents an annual dividend yield of 5.39%. See more information on Banca Mediolanum SpA dividends here
What is Banca Mediolanum SpA’s EPS estimate?
Banca Mediolanum SpA’s EPS estimate is 0.38.
How many shares outstanding does Banca Mediolanum SpA have?
Banca Mediolanum SpA has 745,413,900 shares outstanding.
What happened to Banca Mediolanum SpA’s price movement after its last earnings report?
Banca Mediolanum SpA reported an EPS of €0.384 in its last earnings report, beating expectations of €0.359. Following the earnings report the stock price went up 1.97%.
Which hedge fund is a major shareholder of Banca Mediolanum SpA?
Currently, no hedge funds are holding shares in IT:BMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Banca Mediolanum SpA
Banca Mediolanum S.p.A. is an Italian financial institution that delivers a broad spectrum of banking and financial solutions. Its offerings encompass fundamental services like checking accounts, diverse lending options including mortgages, and a variety of payment cards such as debit, credit, and prepaid. Additionally, the company facilitates wealth growth through savings instruments, investment vehicles like stocks and bonds, and brokerage services. Beyond traditional banking, it also provides insurance and retirement planning products. The organization was established in 1982, with its primary operations based in Basiglio, Italy.
BMED Company Deck
BMED Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlights broad-based growth across revenue lines, strong net income and operating margin expansion, healthy commercial flows and robust capital ratios. Strategic initiatives (Grandi Patrimoni, Banker recruitment, AI deployment) are contributing to higher-quality and more diversified growth. Lowlights are manageable and largely relate to timing effects (deferred performance fees, certificate seasonality), a modest rise in loan impairments, a temporary leverage ratio decline due to front-loaded government bond purchases, and sensitivity of future NII to rates. On balance the positives substantially outweigh the negatives.View all IT:BMED earnings summariesBMED Stock 12 Month Forecast
Average Price Target
€24.33
▲(7.01% Upside)
Technical Analysis
Banca Generali SpA
―
Banco BPM S.p.A.
―
FinecoBank SpA
―
Intesa Sanpaolo SpA
―
Mediobanca Banca di Credito Finanziario S.p.A.
―